EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Modernizing diagnosis of Alzheimer's disease: A review of global trends and Asia‐specific perspectives

Takeshi Iwatsubo, Reisa A Sperling, Alicia Algeciras-Schimnich, Hidenori Arai, Anna M Barron, Tammie L S Benzinger, Maria C Carrillo, Christopher Chen, Seong Hye Choi, Igor C Fontana, Jonathan Graff-Radford, Joshua D Grill und 32 weitere

Alzheimer's & Dementia · 2025-08 · 21 (8)

DOI: 10.1002/alz.70536 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Alzheimer's & Dementia, online erschienen am 04.08.2025. Verfasst von Takeshi Iwatsubo und 43 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neuropathology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan. Hauptthemen laut MEDLINE: Alzheimer Disease. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 124 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Gates Ventures, NIH HHS, Eisai.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The landscape of Alzheimer's disease (AD) and related dementias (ADRD) diagnosis is evolving rapidly, driven by advances in disease understanding, biomarker tools, and disease‐modifying therapies. Modern diagnostic approaches emphasize biological precision, early detection, and dynamic frameworks that adapt to treatment‐induced changes in disease biology. These frameworks enable opportunities for personalized interventions—encompassing pharmacological and non‐pharmacological strategies—and for enhanced clinical trial design. However, implementing these advancements globally is influenced by diverse cultural, infrastructural, and regulatory factors. The 2024 Alzheimer's Association International Conference Advancements: Modernizing Diagnosis, held in Japan, provided a unique platform to explore these global dynamics, particularly from an Asian perspective. This article highlights key discussions from the conference, exploring the role of biomarker‐based diagnostic frameworks in shaping the future of AD/ADRD research, diagnosis, and treatment. We highlight regional challenges and successes and emphasize ethical considerations and practical strategies needed to ensure equitable access to diagnostic and therapeutic innovations. Highlights Advances in biomarkers are reshaping Alzheimer's disease diagnosis and treatment. Modern diagnostic frameworks highlight biological precision, early detection, and dynamic frameworks. The 2024 Alzheimer's Association International Conference Advancements: Modernizing Diagnosis explored challenges and opportunities in global biomarker implementation. The conference explored geographic‐specific impacts, focusing on Asia.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseHumansBiomarkersAsiaEarly Diagnosis

Stichwörter der Autor:innen

Alzheimer's diseaseAsiabiomarkerdementiadiagnosis

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Department of Neuropathology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
  • Center for Alzheimer Research and Treatment, Brigham and Women's Hospital, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
  • Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.
  • National Center for Geriatrics and Gerontology, Obu, Japan.
  • Lee Kong Chian School of Medicine, Nanyang Technological University Singapore, Singapore, Singapore.
  • Mallinckrodt Institute of Radiology, Neuroradiology Section, Washington University, St. Louis, Missouri, USA.

ORCID-Profile: Simin Mahinrad

Förderung

  • Gates Ventures
  • NIH HHS
  • Eisai
  • European Union's Horizon 2020 research and innovation programme
  • Roche Nederland
  • NIA NIH HHS
  • Combinostics
  • Alzheimer's Association

Zitieren

APA

Iwatsubo, T., Sperling, R. A., Algeciras-Schimnich, A., Arai, H., Barron, A. M., Benzinger, T. L. S., Carrillo, M. C., Chen, C., Choi, S. H., Fontana, I. C., Graff-Radford, J., Grill, J. D., Heidebrink, J., Hu, C. J., Ihara, R., Ikeuchi, T., Iwata, A., Ip, F. C. F., Fitri, F. I., …, & Sexton, C. E. (2025). Modernizing diagnosis of Alzheimer's disease: A review of global trends and Asia‐specific perspectives. Alzheimer's & Dementia, 21(8). https://doi.org/10.1002/alz.70536

Vancouver

Iwatsubo T, Sperling RA, Algeciras-Schimnich A, Arai H, Barron AM, Benzinger TLS, et al. Modernizing diagnosis of Alzheimer's disease: A review of global trends and Asia‐specific perspectives. Alzheimer's & Dementia. 2025;21(8). doi:10.1002/alz.70536

BibTeX
@article{Iwatsubo2025,
  author = {Iwatsubo, Takeshi and Sperling, Reisa A and Algeciras-Schimnich, Alicia and Arai, Hidenori and Barron, Anna M and Benzinger, Tammie L S and Carrillo, Maria C and Chen, Christopher and Choi, Seong Hye and Fontana, Igor C and Graff-Radford, Jonathan and Grill, Joshua D and Heidebrink, Judith and Hu, Chaur-Jong and Ihara, Ryoko and Ikeuchi, Takeshi and Iwata, Atsushi and Ip, Fanny C F and Fitri, Fasihah Irfani and Jack, Clifford R and Jeong, Jee Hyang and Jia, Jianping and Kandiah, Nagaendran and Kim, SangYun and Kowa, Hisatomo and La Joie, Renaud and Niimi, Yoshiki and Noritake, Ryoji and Okonkwo, Ozioma C and Palmqvist, Sebastian and Rafii, Michael S and Raman, Rema and Shen, Yong and Simuni, Tanya and Snyder, Heather M and Sriwannopas, Orapitchaya and Stoeckel, Luke E and van der Flier, Wiesje M and Wang, Huali and Wilcock, Donna M and Zetterberg, Henrik and Zhou, Jin and Mahinrad, Simin and Sexton, Claire E},
  title = {Modernizing diagnosis of Alzheimer's disease: A review of global trends and Asia‐specific perspectives},
  journal = {Alzheimer's & Dementia},
  year = {2025},
  volume = {21},
  number = {8},
  doi = {10.1002/alz.70536}
}
Kostenlos starten →